Clinical Trial Update: Effects of Roflumilast in Hospitalized Chronic Obstructive Pulmonary Disease( COPD) on Mortality and Re-hospitalization [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the effects of roflumilast on mortality and re-hospitalization in hospitalized COPD patients; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: Temple University | Conditions: COPD | Phase 3 | Status: COMPLETED | Results posted: 2020-03-12